Another incredible story of CAR T-cell therapy saving an Australian blood cancer patient’s life. However, the young mum had to travel to the USA for treatment. To hear her story click here. Snowdome is raising
The Federal Government announced that it will fund Chimeric Antigen Receptor T cell (CAR T-cell) therapy with Kymriah for the treatment of acute lymphoblastic leukaemia (ALL) in paediatric and young adult patients who have relapsed
As of 1st May 2019 Inotuzumab (Besponsa) will be available on the PBS for patients with relapsed acute lymphocytic leukaemia (ALL) or refractory CD22 positive B-cell precursor ALL. The treatment costs $120,000 per course but
Chimeric Antigen Receptor T-cell (CAR T-cell) therapies are providing Australian blood cancer patients with real hope. From the Federal Government announcing an investment in the Peter MacCallum Cancer Centre to support CAR T-cell treatment to
The FireFlies Antipodes suffered on their bikes for 800kms in order to raise funds for blood cancer research. Snowdome co-Founder Grant Rutherford joined the FireFlies, here is his story. For those who suffered, I drove.